Litcius/Paper detail

A potent and selective CXCR2 antagonist improves neuroimmune dysregulation through the inhibition of NF-κB and notch inflammatory signaling in the BTBR mouse model of autism

Hatun A. Alomar, Mushtaq Ahmad Ansari, Ahmed Nadeem, Sabry M. Attia, Saleh A. Bakheet, Haneen A. Al‐Mazroua, Marwa H. Hussein, Saleh A. Alqarni, Sheikh F. Ahmad

2023Journal of Neuroimmunology14 citationsDOI

Topics & Concepts

CD40AntagonistChemokineEndocrinologyInternal medicineImmunologyMedicineChemistryReceptorBiochemistryIn vitroCytotoxic T cellImmune Response and InflammationNF-κB Signaling PathwaysAntimicrobial Peptides and Activities
A potent and selective CXCR2 antagonist improves neuroimmune dysregulation through the inhibition of NF-κB and notch inflammatory signaling in the BTBR mouse model of autism | Litcius